Zannoni, Gian Franco
 Distribuzione geografica
Continente #
NA - Nord America 11.225
AS - Asia 9.870
EU - Europa 8.396
SA - Sud America 2.124
AF - Africa 358
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 16
Totale 32.011
Nazione #
US - Stati Uniti d'America 10.916
SG - Singapore 4.632
CN - Cina 2.062
DE - Germania 2.031
BR - Brasile 1.737
SE - Svezia 1.521
IT - Italia 1.477
VN - Vietnam 1.002
FR - Francia 782
UA - Ucraina 515
IN - India 487
IE - Irlanda 457
GB - Regno Unito 402
ID - Indonesia 309
FI - Finlandia 302
HK - Hong Kong 263
PL - Polonia 244
JP - Giappone 231
RU - Federazione Russa 207
TR - Turchia 166
AR - Argentina 146
BD - Bangladesh 146
CI - Costa d'Avorio 141
CA - Canada 131
NL - Olanda 115
IQ - Iraq 112
MX - Messico 108
EC - Ecuador 75
ZA - Sudafrica 71
AT - Austria 62
KR - Corea 57
PK - Pakistan 52
BE - Belgio 51
ES - Italia 45
CO - Colombia 41
SA - Arabia Saudita 40
IR - Iran 36
MA - Marocco 36
VE - Venezuela 34
UZ - Uzbekistan 31
CL - Cile 29
PH - Filippine 28
EG - Egitto 27
KE - Kenya 27
LT - Lituania 26
RO - Romania 25
JO - Giordania 23
PY - Paraguay 22
CZ - Repubblica Ceca 21
AZ - Azerbaigian 20
IL - Israele 20
CH - Svizzera 19
OM - Oman 16
UY - Uruguay 16
AE - Emirati Arabi Uniti 15
AU - Australia 15
MY - Malesia 15
PE - Perù 14
JM - Giamaica 13
NP - Nepal 13
TN - Tunisia 12
KZ - Kazakistan 11
LB - Libano 11
AL - Albania 9
BO - Bolivia 9
DO - Repubblica Dominicana 9
HN - Honduras 9
RS - Serbia 9
BG - Bulgaria 8
BH - Bahrain 8
LV - Lettonia 8
PS - Palestinian Territory 8
PT - Portogallo 8
TT - Trinidad e Tobago 8
TW - Taiwan 8
DZ - Algeria 7
ET - Etiopia 7
HU - Ungheria 7
KG - Kirghizistan 7
MD - Moldavia 7
PA - Panama 7
SY - Repubblica araba siriana 7
EU - Europa 6
NZ - Nuova Zelanda 6
SN - Senegal 6
AO - Angola 5
BY - Bielorussia 5
CR - Costa Rica 5
GT - Guatemala 5
NO - Norvegia 5
XK - ???statistics.table.value.countryCode.XK??? 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
GR - Grecia 4
MM - Myanmar 4
TH - Thailandia 4
BB - Barbados 3
CY - Cipro 3
GA - Gabon 3
Totale 31.942
Città #
Singapore 2.520
Chandler 1.759
Ashburn 1.109
San Jose 1.055
Beijing 451
Dublin 451
Jacksonville 358
New York 338
Rome 329
Ho Chi Minh City 322
San Mateo 299
Los Angeles 298
Dallas 271
Jakarta 270
Lauterbourg 258
Hanoi 247
Hong Kong 233
Tokyo 208
Boston 202
Warsaw 201
Wilmington 199
Hefei 194
Milan 194
Nanjing 194
Ann Arbor 189
Frankfurt am Main 177
Hyderabad 175
Dearborn 158
The Dalles 154
São Paulo 152
Munich 147
Princeton 147
Abidjan 141
Helsinki 122
Houston 115
Marseille 106
Moscow 106
Council Bluffs 99
Fairfield 98
Cattolica 97
Izmir 96
Seattle 95
Woodbridge 94
Lawrence 79
Nürnberg 76
Santa Clara 75
Redwood City 74
Nanchang 68
Chicago 67
Buffalo 66
Rio de Janeiro 58
Da Nang 56
Bremen 55
Brooklyn 54
Paris 53
Seoul 51
London 50
Atlanta 48
Brussels 48
Hangzhou 48
Baghdad 47
Orem 45
Zhengzhou 45
Boardman 44
Redmond 44
Turku 44
Denver 43
Norwalk 43
Brasília 42
Haiphong 42
Kent 39
Lappeenranta 39
Tianjin 39
Chennai 36
Düsseldorf 35
Lancaster 35
Stockholm 35
Johannesburg 34
Nuremberg 34
St Louis 34
Vienna 34
Belo Horizonte 33
Hebei 33
Jiaxing 33
Shanghai 33
Toronto 33
Cambridge 32
Changsha 32
Mexico City 32
Amsterdam 31
Curitiba 31
Montreal 31
Phoenix 31
Augusta 30
Shenyang 30
Dhaka 29
Falkenstein 29
Kunming 29
Mountain View 29
Quito 29
Totale 16.877
Nome #
Chromosome 9p deletion syndrome and sex reversal: novel findings and redefinition of the critically deleted regions 443
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 310
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma 302
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. 221
Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study 215
Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma 213
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data 206
Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery. 202
Chromosome 9p deletion syndrome and sex reversal: novel findings and redefinition of the critically deleted regions. 191
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney 188
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology. 187
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 185
Application of liquid-based cytology to fine-needle aspiration biopsies of the thyroid gland 183
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 174
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 171
A case of isolated ovarian recurrence from vulvar carcinoma. 168
Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria 168
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer 168
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia) 168
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 164
Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma 162
Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. 162
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer. 161
Semiquantitative evaluation of lymph-vascular space invasion in patients affected by endometrial cancer: Prognostic and clinical implications 160
Fusion imaging in the preoperative assessment of the extension of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings 160
[Laparoscopic diagnosis of peritoneal endometriosis] 159
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 159
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 158
Should a renal biopsy be performed at the first relapse of 'clinical nephrotic syndrome'? 156
Secondary malignancies of the uterine cervix: a potential diagnostic pitfall 154
Placental and infant metastasis of maternal melanoma: a new case. 154
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo 153
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 153
Mesonephric-like adenocarcinoma of the endometrium: detailed molecular characterization of the first case showing a morphological continuum from mesonephric-like metaplasia and atypical mesonephric-like hyperplasia to adenocarcinoma 152
RNA (E6/E7) versus DNA (E6/E7) assays for risk evaluation in women infected with Human Papillomavirus (HPV) 152
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsie 152
Fetal Doppler velocimetry and bronchopulmonary dysplasia risk among growth-restricted preterm infants: An observational study 152
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations 152
Changes in the expression of oestrogen receptors and E-cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma 150
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients 149
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 149
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 149
Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trial 149
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 146
Management of adnexal masses with unexpected intracystic vegetation detected during laparoscopy. 146
Imaging in gynecological disease (13): clinical and ultrasound characteristics of endometrioid ovarian cancer 144
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 144
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer 143
Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models 142
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery 142
Simultaneous ovarian and endometrial osseous metaplasia: a case report 141
A) Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation 140
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 139
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 139
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma 139
Placental and infant metastasis of maternal melanoma: A new case. 139
Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors 139
Imaging in gynecological disease (14): clinical and ultrasound characteristics of ovarian clear cell carcinoma 139
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 139
Uterine tumor resembling ovarian sex-cord tumor: Conservative surgery with successful delivery and case series 139
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 138
Aymptomatic intrathyroidal parathyroid adenoma: case report and differential diagnosis with thyroid neoplasms 138
The vulvar immunohistochemical panel (Vip) project: Molecular profiles of vulvar squamous cell carcinoma 138
Placental and infant metastasis of maternal melanoma: A new case. 137
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers 137
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 137
Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group 136
Minimally Invasive Approach in Type II Endometrial Cancer: Is It Wise and Safe? 135
Thyroid fine-needle aspiration cytology processed by ThinPrep: an additional slide decreased the number of inadequate results 134
Diagnostic efficacy of conventional as compared to liquid-based cytology in thyroid lesions. Evaluation of 10,360 fine needle aspiration cytology cases 134
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases 134
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 132
Sexual dimorphism in medulloblastoma features 132
Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization 131
Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical-pathological and immunohistochemical study 131
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 131
Imaging in gynecological disease (11): clinical and ultrasound features of mucinous ovarian tumors 131
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 131
Histopathological evaluation of tumor-infiltrating lymphocytes (TILs) as predictive biomarker for hormone receptors status, proliferative activity and clinical outcome in her-2 positive breast cancer 131
Sonographic features of primary ovarian fibrosarcoma: a report of two cases. 129
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 129
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 129
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo. 128
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations 128
Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations 128
Morphology and immunophenotyping of a monolateral ovotestis in a 46,XderY/45,X mosaic individual with ambiguous genitalia 127
FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases 127
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma 126
Clinicopathological analysis of mixed endometrial carcinomas: clinical relevance of different neoplastic components 126
Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications 126
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 125
Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment 125
The role of liquid based cytology and ancillary techniques in the peritoneal washing analysis: Our institutional experience 125
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 125
Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role? 124
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 124
Endometrial Metaplastic/Reactive Changes Coexistent with Endometrial Hyperplasia and Carcinoma: A Morphological and Immunohistochemical Study 124
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY) 122
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer 122
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer 122
Totale 15.373
Categoria #
all - tutte 133.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021388 0 0 0 0 0 0 0 0 0 127 218 43
2021/20221.964 144 113 36 189 99 62 47 316 84 104 339 431
2022/20234.592 560 637 340 683 241 594 281 391 554 61 165 85
2023/20242.358 93 674 77 126 82 343 138 98 49 134 289 255
2024/20255.284 75 129 363 206 383 221 237 214 702 651 1.148 955
2025/202612.789 1.937 450 998 1.655 2.272 718 2.376 686 917 780 0 0
Totale 32.514